A Study to Investigate the Impact of Fortified Malt Based on Immunity Outcomes in School Children

Clinical trial NCT02542865 · COMPLETED

Trial details

NCT number: NCT02542865
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Growth and Development

Start date: 2017-07-24
Primary completion: 2018-07-06
Enrollment: 924

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.